Among 63 adults with Down syndrome aged over 40 whose brains were examined after death, Alzheimer's disease neuropathological change occurring on its own, with no additional pathology, was found in only 18 people, or 29 per cent. The remainder carried at least one further disease process alongside it. The analysis, by Lisi Flores-Aguilar, Elizabeth Head and colleagues, was published in Acta Neuropathologica on 15 May 2026 and used the standardised neuropathology forms of the National Alzheimer's Coordinating Center, applied to a cohort characterised both clinically and at autopsy. The authors describe it as the first systematic characterisation of co-pathology frequency in this population.
Cerebral amyloid angiopathy, amyloid deposited in the walls of blood vessels rather than the brain tissue, was by far the most common companion, present in about 84 per cent of the series; graded moderate to severe, it appeared in 38 of 63 cases (60 per cent), alone or with other pathologies. Lewy pathology was recorded in 21 per cent, hippocampal sclerosis in 19 per cent and limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) in 17 per cent. Atherosclerosis and arteriolosclerosis were infrequent and rarely occurred as an isolated co-pathology. The most common combination was Alzheimer's change plus cerebral amyloid angiopathy plus one other pathology (Lewy, LATE-NC or hippocampal sclerosis), in 15 people (24 per cent), followed by Alzheimer's change plus cerebral amyloid angiopathy in 14 (22 per cent). Cortical and hippocampal atrophy, and moderate to severe loss of pigment in the locus coeruleus, were common across the cohort.
A secondary and explicitly exploratory comparison set 55 people who had dementia against eight from the same cohort who did not. The eight without dementia had larger brain weights, less frequent severe hippocampal atrophy and less locus coeruleus hypopigmentation, and showed intermediate rather than high Alzheimer's change. The authors note that neither LATE-NC nor hippocampal sclerosis was present in that group, while stating that the difference was not statistically significant, and they raise resilience and resistance mechanisms as a possible explanation. Eight people is a very small comparison group, and no causal reading is available from counts of this kind.
The wider point the authors draw is about heterogeneity. Adults with Down syndrome have three copies of the amyloid precursor protein gene on chromosome 21, develop Alzheimer's neuropathological change by about age 40 and most develop dementia in their early 50s, which makes the amyloid trigger effectively uniform. Even so, the pathological combinations found at autopsy varied considerably from person to person. A separate conference abstract from the same group, published in Alzheimer's and Dementia on 23 December 2025 and drawing on 67 autopsy cases from the University of California, Irvine Alzheimer's Disease Research Center, reported that among nine individuals without dementia, cerebral amyloid angiopathy was again the most frequent co-pathology, TDP-43 pathology appeared in one case, Lewy pathology in two and hippocampal sclerosis in none.